About cardiac prosthetic devices
Prosthetic devices are used to replace or support the function of a missing or infirm part in the body. Cardiac prosthetic devices such as stents and prosthetic heart valves are used to maintain the proper functionality of the heart. Stents are used to maintain the blood flow, which reduces due to blockage in the arteries, whereas prosthetic heart valves are being used by patient with heart valvular disease or dysfunctional heart valve.
Technavio's analysts forecast the global cardiac prosthetic market to grow at a CAGR of 8.41% over the period 2014-2019.
Covered in this report
The report covers the present scenario and the growth prospects of the global cardiac prosthetic market for the period 2015-2019. The market can be segmented into two based on products: prosthetic heart valves and coronary stents.
Technavio's report, the Global Cardiac Prosthetic Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and APAC and EMEA; it also covers the global cardiac prosthetic market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key regions
• Americas
• APAC
• EMEA
Key vendors
• Boston Scientific
• Edwards Lifesciences
• Medtronic
• Sorin Group
• St. Jude Medical
Other prominent vendors
• AorTech International
• Abbott Vascular
• Accellent
• Admedes Schuessler
• Alvimedica
• Arbor Surgical
• B. Braun Melsungen
• Biosensors International
• Biotronik
• Boston Scientific
• Bracco AMT
• Colibri Heart Valve
• Elixir Medical
• eucatech
• Eurocor
• Hexacath
• InspireMD
• InSitu Technologies
• iVascular
• LEPU MEDICAL
• Meril Life Sciences
• Merit Medical
• OrbusNeich
• QT Vascular
• Rontis
• SCITECH
• Shanghai MicroPort Scientific
• STENTYS
• Svelte Medical Systems
• Symetis
• Translumina
Market driver
• Rise in birth prevalence of congenital heart disease worldwide
• For a full, detailed list, view our report
Market challenge
• Risk of complications and re-interventions
• For a full, detailed list, view our report
Market trend
• Increase in use of low-profile stents grafts for aneurysm repair
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Cost Analysis of Heart Valve Procedures
08. Pipeline Products
09. Global Cardiac Prosthetic Devices Market Segmentation by Product Type
10. Global Coronary Stents Market
10.1 Market Size and Forecast
10.2 Segmentation of Global Coronary Stents Market by Type
11. Global Heart Valves Market
11.1 Market Size and Forecast
11.2 Mechanical Heart Valves
11.2.1 Market Size and Forecast
11.3 Tissue Heart Valves
11.3.1 Market Size and Forecast
11.4 Transcatheter Heart Valves
11.4.1 Market Size and Forecast
12. Geographical Segmentation
12.1 Cardiac Prosthetic Devices Market in EMEA
12.1.1 Market Size and Forecast
12.2 Cardiac Prosthetic Devices Market in Americas
12.2.1 Facility and Physician Billing Guide for Heart Valve Technologies in 2015
12.2.2 Reimbursement Scenario for Cardiac Prosthetic Devices in US
12.2.3 Market Size and Forecast
12.3 Cardiac Prosthetic Devices Market in APAC
12.3.1 Market Size and Forecast
13. Buying Criteria
14. Market Growth Drivers
15. Drivers and their Impact
16. Market Challenges
17. Impact of Drivers and Challenges
18. Market Trends
19. Trends and their Impact
20. Vendor Landscape
20.1 Competitive Scenario
20.1.1 Key News
20.1.2 Mergers and Acquisitions
20.2 Market Share Analysis 2014
20.3 Other Prominent Vendors
21. Key Vendor Analysis
21.1 Boston Scientific
21.1.1 Key Facts
21.1.2 Business Overview
21.1.3 Business Segmentation
21.1.4 Business Segmentation by Revenue 2013
21.1.5 Business Segmentation by Revenue 2012 and 2013
21.1.6 Geographical Segmentation by Revenue 2013
21.1.7 Business Strategy
21.1.8 Recent Developments
21.1.9 SWOT Analysis
21.2 Edwards Lifesciences
21.2.1 Key Facts
21.2.2 Business Overview
21.2.3 Business Segmentation by Revenue 2013
21.2.4 Business Segmentation by Revenue 2012 and 2013
21.2.5 Geographical Segmentation by Revenue 2013
21.2.6 Business Strategy
21.2.7 Recent Information
21.2.8 SWOT Analysis
21.3 Medtronic
21.3.1 Key Facts
21.3.2 Business Overview
21.3.3 Business Segmentation
21.3.4 Revenue by Business Segmentation
21.3.5 Revenue Comparison by Business Segmentation 2012 and 2013
21.3.6 Revenue by Geographical Segmentation
21.3.7 Business Strategy
21.3.8 Key Developments
21.3.9 SWOT Analysis
21.4 Sorin Group
21.4.1 Key Facts
21.4.2 Business Overview
21.4.3 Business Segmentation by Revenue 2014
21.4.4 Business Segmentation by Revenue 2013 and 2014
21.4.5 Geographical Segmentation by Revenue 2014
21.4.6 Business Strategy
21.4.7 Recent Developments
21.4.8 SWOT Analysis
21.5 St. Jude Medical
21.5.1 Key Facts
21.5.2 Business Description
21.5.3 Business Segmentation
21.5.4 Business Strategy
21.5.5 Revenue Segmentation by Business
21.5.6 Revenue by Geographical Segmentation
21.5.7 Key Information
21.5.8 SWOT Analysis
22. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Cardiac Prosthetic Devices Market 2014-2019 ($ millions)
Exhibit 3: Types of Surgical Option
Exhibit 4: Segmentation of Global Cardiac Prosthetic Devices Market by Product Type
Exhibit 5: Segmentation of Global Cardiac Prosthetic Devices Market by Product Type 2014
Exhibit 6: Global Coronary Stents Market 2014-2019 ($ millions)
Exhibit 7: Segmentation of Coronary Stents by Type
Exhibit 8: Segmentation of Coronary Stents by Type 2014
Exhibit 9: Segmentation of Cardiac Prosthetic Heart Valves by Type
Exhibit 10: Global Heart Valves Market 2014-2019 ($ millions)
Exhibit 11: Segmentation of Mechanical Heart Valves by Type
Exhibit 12: Biomaterials used in Different Valves
Exhibit 13: Characteristics of Mechanical Valves
Exhibit 14: Global Mechanical Heart Valves Market 2014-2019 ($ millions)
Exhibit 15: Global Tissue Heart Valves Market 2014-2019 ($ millions)
Exhibit 16: Global Transcatheter Heart Valves Market 2014-2019 ($ millions)
Exhibit 17: Segmentation of Cardiac Prosthetic Heart Devices 2014
Exhibit 18: Segmentation of Cardiac Prosthetic Heart Devices 2014-2019
Exhibit 19: Segmentation of Cardiac Prosthetic Heart Devices 2014-2019
Exhibit 20: Segmentation of Global Cardiac Prosthetic Devices Market 2014
Exhibit 21: Cardiac Prosthetic Devices Market in EMEA 2014-2019 ($ millions)
Exhibit 22: Cardiac Prosthetic Devices Market in Americas 2014-2019 ($ millions)
Exhibit 23: Cardiac Prosthetic Devices Market in APAC 2014-2019 ($ millions)
Exhibit 24: Segmentation of Global Cardiac Prosthetic Devices Market by Geography 2014-2019
Exhibit 25: Segmentation of Global Cardiac Prosthetic Devices Market by Geography 2014-2019 ($ millions)
Exhibit 26: Key Takeaways: Boston Scientific
Exhibit 27: Key Takeaways: Edwards Lifesciences
Exhibit 28: Key Takeaways: Medtronic
Exhibit 29: Key Takeaways: Sorin
Exhibit 30: Key Takeaways: St. Jude Medical
Exhibit 31: Boston Scientific: Business Segmentation
Exhibit 32: Boston Scientific: Business Segmentation by Revenue 2013
Exhibit 33: Boston Scientific: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 34: Boston Scientific: Geographical Segmentation by Revenue 2013
Exhibit 35: Edwards Lifesciences: Business Segmentation by Revenue 2013
Exhibit 36: Edwards Lifesciences: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 37: Edwards Lifesciences: Geographical Segmentation by Revenue 2013
Exhibit 38: Medtronic Inc.: Business Segmentation
Exhibit 39: Medtronic Inc.: Revenue by Business Segmentation 2013
Exhibit 40: Medtronic Inc.: Revenue Comparison by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 41: Medtronic Inc.: Revenue by Geographical Segmentation 2013
Exhibit 42: Sorin Group: Business Segmentation by Revenue 2014
Exhibit 43: Sorin Group: Business Segmentation by Revenue 2013 and 2014 ($ million)
Exhibit 44: Sorin Group: Geographical Segmentation by Revenue 2014
Exhibit 45: St. Jude Medical: Business Segmentation
Exhibit 46: St. Jude Medical: Revenue by Business Segmentation 2013
Exhibit 47: St. Jude Medical: Revenue by Geographical Segmentation 2012
